12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine

C112H148N32O4S5 — CID 157464508

IUPAC12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine
SMILESCN(C)C1CCC(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3sc4c(c23)CCC4)CC1.CN(C)C1CCC(Oc2nc(Nc3cnn(C)c3)nc3sc4c(c23)CCC4)CC1.Cn1cc(Nc2nc(NC3CCCCC3)c3c4c(sc3n2)CCC4)cn1.c1c[nH]c(Nc2nc(NC3CCC(N4CCOCC4)CC3)c3c4c(sc3n2)CCC4)n1.c1c[nH]c(Nc2nc(NC3CCC(N4CCOCC4)CC3)c3c4c(sc3n2)CCCC4)n1
InChIInChI=1S/C27H36N6OS.C23H31N7OS.C22H29N7OS.C21H28N6OS.C19H24N6S/c1-32(2)19-10-12-21(13-11-19)34-25-24-22-4-3-5-23(22)35-26(24)31-27(30-25)29-18-6-8-20(9-7-18)33-16-14-28-15-17-33;1-2-4-18-17(3-1)19-20(27-23(28-21(19)32-18)29-22-24-9-10-25-22)26-15-5-7-16(8-6-15)30-11-13-31-14-12-30;1-2-16-17(3-1)31-20-18(16)19(26-22(27-20)28-21-23-8-9-24-21)25-14-4-6-15(7-5-14)29-10-12-30-13-11-29;1-26(2)14-7-9-15(10-8-14)28-19-18-16-5-4-6-17(16)29-20(18)25-21(24-19)23-13-11-22-27(3)12-13;1-25-11-13(10-20-25)22-19-23-17(21-12-6-3-2-4-7-12)16-14-8-5-9-15(14)26-18(16)24-19/h6-9,19,21,28H,3-5,10-17H2,1-2H3,(H,29,30,31);9-10,15-16H,1-8,11-14H2,(H3,24,25,26,27,28,29);8-9,14-15H,1-7,10-13H2,(H3,23,24,25,26,27,28);11-12,14-15H,4-10H2,1-3H3,(H,23,24,25);10-12H,2-9H2,1H3,(H2,21,22,23,24)
InChIKeyBUHSOCPQRVVOHO-UHFFFAOYSA-N
MW2166.97 g/mol
LogP20.69
Rot. Bonds25

About 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine

12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine (PubChem CID 157464508) has the molecular formula C112H148N32O4S5 and a molecular weight of 2166.97 g/mol. Its IUPAC name is 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine.

Molecular Properties

Compound Name12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine
PubChem CID157464508
Molecular FormulaC112H148N32O4S5
Molecular Weight2166.97 g/mol
Exact Mass2165.10
IUPAC Name12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine
SMILESCN(C)C1CCC(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3sc4c(c23)CCC4)CC1.CN(C)C1CCC(Oc2nc(Nc3cnn(C)c3)nc3sc4c(c23)CCC4)CC1.Cn1cc(Nc2nc(NC3CCCCC3)c3c4c(sc3n2)CCC4)cn1.c1c[nH]c(Nc2nc(NC3CCC(N4CCOCC4)CC3)c3c4c(sc3n2)CCC4)n1.c1c[nH]c(Nc2nc(NC3CCC(N4CCOCC4)CC3)c3c4c(sc3n2)CCCC4)n1
InChIInChI=1S/C27H36N6OS.C23H31N7OS.C22H29N7OS.C21H28N6OS.C19H24N6S/c1-32(2)19-10-12-21(13-11-19)34-25-24-22-4-3-5-23(22)35-26(24)31-27(30-25)29-18-6-8-20(9-7-18)33-16-14-28-15-17-33;1-2-4-18-17(3-1)19-20(27-23(28-21(19)32-18)29-22-24-9-10-25-22)26-15-5-7-16(8-6-15)30-11-13-31-14-12-30;1-2-16-17(3-1)31-20-18(16)19(26-22(27-20)28-21-23-8-9-24-21)25-14-4-6-15(7-5-14)29-10-12-30-13-11-29;1-26(2)14-7-9-15(10-8-14)28-19-18-16-5-4-6-17(16)29-20(18)25-21(24-19)23-13-11-22-27(3)12-13;1-25-11-13(10-20-25)22-19-23-17(21-12-6-3-2-4-7-12)16-14-8-5-9-15(14)26-18(16)24-19/h6-9,19,21,28H,3-5,10-17H2,1-2H3,(H,29,30,31);9-10,15-16H,1-8,11-14H2,(H3,24,25,26,27,28,29);8-9,14-15H,1-7,10-13H2,(H3,23,24,25,26,27,28);11-12,14-15H,4-10H2,1-3H3,(H,23,24,25);10-12H,2-9H2,1H3,(H2,21,22,23,24)
InChIKeyBUHSOCPQRVVOHO-UHFFFAOYSA-N
XLogP20.69
TPSA383.29 Ų
H-Bond Donors11
H-Bond Acceptors39
Rotatable Bonds25
Heavy Atoms153
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002166.97
LogP ≤ 520.69
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine?
The IUPAC name of 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine (CID 157464508) is 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine.
What is the SMILES notation for 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine?
The canonical SMILES for 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine is CN(C)C1CCC(Oc2nc(Nc3ccc(N4CCNCC4)cc3)nc3sc4c(c23)CCC4)CC1.CN(C)C1CCC(Oc2nc(Nc3cnn(C)c3)nc3sc4c(c23)CCC4)CC1.Cn1cc(Nc2nc(NC3CCCCC3)c3c4c(sc3n2)CCC4)cn1.c1c[nH]c(Nc2nc(NC3CCC(N4CCOCC4)CC3)c3c4c(sc3n2)CCC4)n1.c1c[nH]c(Nc2nc(NC3CCC(N4CCOCC4)CC3)c3c4c(sc3n2)CCCC4)n1.
What is the InChIKey of 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine?
The InChIKey is BUHSOCPQRVVOHO-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H36N6OS.C23H31N7OS.C22H29N7OS.C21H28N6OS.C19H24N6S/c1-32(2)19-10-12-21(13-11-19)34-25-24-22-4-3-5-23(22)35-26(24)31-27(30-25)29-18-6-8-20(9-7-18)33-16-14-28-15-17-33;1-2-4-18-17(3-1)19-20(27-23(28-21(19)32-18)29-22-24-9-10-25-22)26-15-5-7-16(8-6-15)30-11-13-31-14-12-30;1-2-16-17(3-1)31-20-18(16)19(26-22(27-20)28-21-23-8-9-24-21)25-14-4-6-15(7-5-14)29-10-12-30-13-11-29;1-26(2)14-7-9-15(10-8-14)28-19-18-16-5-4-6-17(16)29-20(18)25-21(24-19)23-13-11-22-27(3)12-13;1-25-11-13(10-20-25)22-19-23-17(21-12-6-3-2-4-7-12)16-14-8-5-9-15(14)26-18(16)24-19/h6-9,19,21,28H,3-5,10-17H2,1-2H3,(H,29,30,31);9-10,15-16H,1-8,11-14H2,(H3,24,25,26,27,28,29);8-9,14-15H,1-7,10-13H2,(H3,23,24,25,26,27,28);11-12,14-15H,4-10H2,1-3H3,(H,23,24,25);10-12H,2-9H2,1H3,(H2,21,22,23,24).
What are the key properties of 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine?
12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine has a molecular weight of 2166.97 g/mol, XLogP of 20.69, 25 rotatable bonds, 11 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 12-N-cyclohexyl-10-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(1-methylpyrazol-4-yl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;12-[4-(dimethylamino)cyclohexyl]oxy-N-(4-piperazin-1-ylphenyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-10-amine;2-N-(1H-imidazol-2-yl)-4-N-(4-morpholin-4-ylcyclohexyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidine-2,4-diamine;10-N-(1H-imidazol-2-yl)-12-N-(4-morpholin-4-ylcyclohexyl)-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraene-10,12-diamine is sourced from PubChem (CID 157464508), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).